Compare Eli Lilly And Co (LLY) vs First Trust NASDAQ 100 Technology Index Fund (QTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs First Trust NASDAQ 100 Technology Index Fund — how do they compare? Eli Lilly And Co trades at $1,160 (market cap $1.02T), while First Trust NASDAQ 100 Technology Index Fund trades at $309.9. The key difference: Eli Lilly And Co pays a 0.6% dividend while First Trust NASDAQ 100 Technology Index Fund pays none. Which is the better fit depends on your goals.
| LLY | QTEC | |
|---|---|---|
Market Cap | $1.02T | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.24K | $335.74 |
52-Week Low | $625.65 | $207.03 |
Enterprise Value | $1.06T | — |
Dividend Yield | 0.6% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.
Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.
QTEC trades at $301.50, up 0.53% today, with a bearish technical signal overall. Key support lies at $298 and resistance at $302. The ETF provides equal-weighted exposure to top technology firms, tracking the Nasdaq-100 Technology Sector Index. Recent news highlights its broad tech sector focus and questions on AI and chip stock valuations.
Outlook remains tied to technology sector performance, with risks from market volatility and sector-specific headwinds. Investment opportunity lies in targeted tech exposure, but caution is warranted given overheated valuations in segments like AI.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About First Trust NASDAQ 100 Technology Index Fund
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →
